Fusion Pharmaceuticals Cash from Financing (TTM) Analysis

Fusion Pharmaceuticals Inc (FUSN)

21.42 0.00 (0.00%) USD | NASDAQ | May 07, 16:00

21.42 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	142.01M
September 30, 2023	84.28M
June 30, 2023	112.86M
March 31, 2023	98.54M
December 31, 2022	40.73M
September 30, 2022	40.55M
June 30, 2022	11.70M
March 31, 2022	1.926M
December 31, 2021	0.347M

Date	Value
September 30, 2021	0.453M
June 30, 2021	-1.90M
March 31, 2021	255.73M
December 31, 2020	265.51M
September 30, 2020	265.45M
June 30, 2020	267.75M
March 31, 2020	9.907M
December 31, 2019	52.19M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.90M

Minimum

Jun 2021

267.75M

Maximum

Jun 2020

96.94M

Average

52.19M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks